Order book during the quarter jumped 57 per cent year on year at Rs 1,497 crore as against Rs 952 crore, aided by broad based industrial recovery
With the past two day's rally, it has recovered 15 per cent from its recent low of Rs 1,401, hit on May 4, in intra-day trade
The management expects the April-June quarter (Q1FY22) to be relatively weak due to the pandemic and expect to improve gradually from the second quarter
The stock was trading close to its record high level of Rs 522 touched on February 9, 2018
The management said that with the gradual opening of the economy and reopening of outlets, the company saw month-on-month increase in sales from dine-in and delivery channels
The domestic paints industry commands strong pricing power, which is evident from frequent price hikes amid inflationary raw material prices
If Tata Steel's stock does not recover the gap-down range, the downside bias may drag it towards Rs 1040 levels.
Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Panacea Biotech announced the launch of production of the Russian Sputnik V vaccine against coronavirus
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients popularly known as Black Fungus
According to a media report, Clarios was to sell 17.1 million shares for an aggregate of $174 million today
A total of 68 companies are slated to post their March quarter results today, including Alkem Labs, AstraZeneca Pharma India, Stove Kraft, Emami, Thermax and VIP Industries
HEG is scheduled to announce its March quarter results on Thursday, May 27, 2021
If these stocks manage to cross their significant resistances, the upside may result in a surge of over 5 per cent
Recovery in key international markets, continuous focus on infrastructure by the government, and rebound in crude oil prices augur well for L&T, according to analysts
The stock has surpassed its previous 52-week high of Rs 644, touched on March 4, 2021
A healthy monsoon and harvest season along with a rebound in GDP should aid the industry's recovery from Q2 onwards, Hero MotoCorp management said
The company reported a profit after tax (PAT) of Rs 9.9 crore in Q4FY21, on the back of healthy revenue growth, against loss of Rs 7.6 crore in Q4FY20
The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US
Total slippages and restructuring for FY21 were at Rs 46,416 crore, within the guidance of Rs 60,000 crore
Grasim Industries, India Cements, JK Paper, Mahanagar Gas and Barbeque-Nation Hospitality are among 33 companies slated to post their quarterly numbers today